medigraphic.com
ISSN 1029-3043 (Electronic)

2023, Number 1

<< Back Next >>

Medicentro 2023; 27 (1)

Morphea in childhood

Camero MJC, Anuy EK, Fajardo, Curbelo FJC

Language: Spanish
References: 13
Page:
PDF size: 514.45 Kb.


ABSTRACT

Morphea is a rare fibrosing disease of the skin and underlying tissues which is more common in women and can appear at any age. It is an autoimmune and benign disease with spontaneous remission or chronic relapsing course; it is characterized by the appearance of single or multiple, rounded or linear, asymptomatic, chronically evolving sclerosed skin areas without systemic involvement. We present a female pediatric patient with this disease, whose symptoms, diagnostic examination and histology were compatible with linear morphea that, despite the delay in its diagnosis, she had a favorable evolution once immunosuppressive treatment was started, and physiotherapy was simultaneously performed.


REFERENCES

  1. Crespo MP, Mas Ib, Díaz JM, Costa AL, Nortes IB. Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in Young girl. Pediatr Dermatol [internet]. 2009 [citado 29 feb. 2020];26(1):[aprox. 2 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19250434/1.

  2. Cordero A. Morfea. el desequilibrio entre la producción y la destrucción del colágeno. Rev Med Cos [internet]. 2016 [citado 29 feb. 2020];73:[aprox. 3 p.]. Disponible en: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2016/rmc162zb.pdf2.

  3. Romero DB, Soledad Zegpi MT, Celso Castillo A, González SB, Torres SF. Morfea en niños: revisión bibliográfica y puesta al día. Rev Chil Pediatr [internet]. 2004 [citado 29 feb. 2020];75(2):[aprox. 6 p.]. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0370-410620040002000103.

  4. Frumholtz L, Roux J, Bagot M, Rybojad M, Bouaziz JD. Treatment of generalized Deep Morphea with everolimus. JAMA Dermatol [internet]. 2016 [citado 29 feb. 2020];152(10):[aprox. 2 p.]. Disponible en: https://jamanetwork.com/journals/jamadermatology/fullarticle/25360634.

  5. Mertens JS, Marsman D, Van de Kerkhof PC, Hoppenreijs EP, Knaapen HK, Radstake TR. Use of mycophenolate Mofetil in Patients with severe localized scleroderma resistant or intolerant to methotrexate. Acta Derm Venereol [internet]. 2016 [citado 9 mayo 2020];96(4):[aprox. 3 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26582717/5.

  6. Dytoc M, Ting PT, Man J, Sawyer D, Fiorillo L. First case series on the use of imiquimod 5% for plaque-type morphea: a multicenter, prospective, vehicle-controlled trial. J Cutan Med Surg [internet]. 2015 [citado 23 jun. 2020];19(2):[aprox. 7 p.]. Disponible en: https://www.researchgate.net/publication/7583575_First_case_series_on_the_use_of_imiquimod_for_morphea6.

  7. Hanami Y, Ohtsuka M, Yamamoto T. Paraneoplastic eosniphilic fascitis with generalized morphea and vitiligo in a patient working with organic solvents. J Dermatol [internet]. 2016 [citado 3 jul. 2020];43(1):[aprox. 1 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26507670/7.

  8. Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A. German guidlines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges [internet]. 2016. [citado 8 jul. 2020];14(2):[aprox. 17 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26819124/8.

  9. García de la Peña-Lefebvre P. Esclerodermia localizada. Protoc Diagn Ter Pediatr [internet]. 2014 [citado 3 jul. 2020];1:[aprox. 5 p.]. Disponible en: https://www.aeped.es/sites/default/files/documentos/5-esclerodermia.pdf9.

  10. Strickler A, Gallo S, Jaramillo P, de Toro G. Morfea o esclerodermia localizada juvenil, caso clínico. Rev Chil Pediatr [internet]. 2016 [citado 3 jul. 2020];87(4):[aprox. 4 p.]. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_abstract&pid=S0370-41062016000400008&lng=en&nrm=iso&tlng=es10.

  11. Mazori DR, Wright NA, Patel M, Liu SW, Ramachandran SM, Franks AG Jr, et al. characteritics and treatment of adult-onset linear morphea: a restropective cohort study of 61 patients at 3 tertiary care centers. J Am Acad Dermatol [internet]. 2016 [citado 3 jul. 2020];74(3):[aprox. 2 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26892661/11.

  12. Careta MF, Romiti R. Review Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol [internet]. 2015 [citado 3 jul. 2020];90(1):[aprox. 11 p.]. Disponible en: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000100062&lng=en&tlng=en12.

  13. Rattanakaemakorn P, Jorizzo J. The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype). J Dermatol Treat [internet]. 2018 [citado 3 jul. 2020];29(2):[aprox. 2 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28604132/13.




2020     |     www.medigraphic.com